Chemours Company (The) (NYSE: CC) is one of 35 publicly-traded companies in the “Commodity Chemicals” industry, but how does it contrast to its peers? We will compare Chemours Company (The) to similar businesses based on the strength of its earnings, analyst recommendations, risk, profitability, institutional ownership, dividends and valuation.

Analyst Recommendations

This is a breakdown of recent ratings for Chemours Company (The) and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours Company (The) 0 0 6 0 3.00
Chemours Company (The) Competitors 104 774 1163 34 2.54

Chemours Company (The) presently has a consensus target price of $51.83, indicating a potential downside of 8.98%. As a group, “Commodity Chemicals” companies have a potential downside of 1.01%. Given Chemours Company (The)’s peers higher possible upside, analysts plainly believe Chemours Company (The) has less favorable growth aspects than its peers.

Valuation and Earnings

This table compares Chemours Company (The) and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Chemours Company (The) $5.74 billion $1.07 billion 38.48
Chemours Company (The) Competitors $4.16 billion $893.20 million 33.99

Chemours Company (The) has higher revenue and earnings than its peers. Chemours Company (The) is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.


This table compares Chemours Company (The) and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Chemours Company (The) 4.96% 122.97% 6.77%
Chemours Company (The) Competitors -23.11% 24.03% 5.72%

Insider and Institutional Ownership

72.8% of Chemours Company (The) shares are owned by institutional investors. Comparatively, 69.0% of shares of all “Commodity Chemicals” companies are owned by institutional investors. 1.1% of Chemours Company (The) shares are owned by insiders. Comparatively, 8.3% of shares of all “Commodity Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.


Chemours Company (The) pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Chemours Company (The) pays out 8.1% of its earnings in the form of a dividend. As a group, “Commodity Chemicals” companies pay a dividend yield of 1.8% and pay out 63.1% of their earnings in the form of a dividend.

Volatility & Risk

Chemours Company (The) has a beta of 3.6, indicating that its stock price is 260% more volatile than the S&P 500. Comparatively, Chemours Company (The)’s peers have a beta of 1.17, indicating that their average stock price is 17% more volatile than the S&P 500.


Chemours Company (The) beats its peers on 11 of the 15 factors compared.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with's FREE daily email newsletter.